6.
King K, Aguirre A, Ye Y, Sun Y, Roh J, Ng Jr R
. IRF3 and type I interferons fuel a fatal response to myocardial infarction. Nat Med. 2017; 23(12):1481-1487.
PMC: 6477926.
DOI: 10.1038/nm.4428.
View
7.
Kunkler I, Williams L, Jack W, Cameron D, Dixon J
. Breast-conserving surgery with or without irradiation in women aged 65 years or older with early breast cancer (PRIME II): a randomised controlled trial. Lancet Oncol. 2015; 16(3):266-73.
DOI: 10.1016/S1470-2045(14)71221-5.
View
8.
Mariotto A, Etzioni R, Hurlbert M, Penberthy L, Mayer M
. Estimation of the Number of Women Living with Metastatic Breast Cancer in the United States. Cancer Epidemiol Biomarkers Prev. 2017; 26(6):809-815.
PMC: 5833304.
DOI: 10.1158/1055-9965.EPI-16-0889.
View
9.
. Comprehensive molecular portraits of human breast tumours. Nature. 2012; 490(7418):61-70.
PMC: 3465532.
DOI: 10.1038/nature11412.
View
10.
Liang Y, Zhang H, Song X, Yang Q
. Metastatic heterogeneity of breast cancer: Molecular mechanism and potential therapeutic targets. Semin Cancer Biol. 2019; 60:14-27.
DOI: 10.1016/j.semcancer.2019.08.012.
View
11.
Jemal A, Robbins A, Lin C, Flanders W, DeSantis C, Ward E
. Factors That Contributed to Black-White Disparities in Survival Among Nonelderly Women With Breast Cancer Between 2004 and 2013. J Clin Oncol. 2017; 36(1):14-24.
DOI: 10.1200/JCO.2017.73.7932.
View
12.
Soran A, Ozmen V, Ozbas S, Karanlik H, Muslumanoglu M, Igci A
. Randomized Trial Comparing Resection of Primary Tumor with No Surgery in Stage IV Breast Cancer at Presentation: Protocol MF07-01. Ann Surg Oncol. 2018; 25(11):3141-3149.
DOI: 10.1245/s10434-018-6494-6.
View
13.
Israel I, Margenthaler J
. Surgical Extirpation of the Primary Tumor in Stage IV Breast Cancer: The Debate Continues. J Am Coll Surg. 2021; 233(6):751-752.
DOI: 10.1016/j.jamcollsurg.2021.09.002.
View
14.
Lyu X, Luo B
. Prognostic factors and survival prediction in HER2-positive breast cancer with bone metastases: A retrospective cohort study. Cancer Med. 2021; 10(22):8114-8126.
PMC: 8607243.
DOI: 10.1002/cam4.4326.
View
15.
Zheng A, Guo B, Zhang J, Jin F
. Clinical information and management status of de novo stage IV breast cancer patients: a Chinese multicenter investigation (CSBrS-002). Chin Med J (Engl). 2021; 134(13):1569-1575.
PMC: 8280017.
DOI: 10.1097/CM9.0000000000001415.
View
16.
Sidaway P
. Radiotherapy can be omitted for older patients with low-risk disease. Nat Rev Clin Oncol. 2023; 20(4):210.
DOI: 10.1038/s41571-023-00750-5.
View
17.
Grimes D
. The nomogram epidemic: resurgence of a medical relic. Ann Intern Med. 2008; 149(4):273-5.
DOI: 10.7326/0003-4819-149-4-200808190-00010.
View
18.
Gogate A, Wheeler S, Reeder-Hayes K, Ekwueme D, Fairley T, Drier S
. Projecting the Prevalence and Costs of Metastatic Breast Cancer From 2015 through 2030. JNCI Cancer Spectr. 2021; 5(4).
PMC: 8364673.
DOI: 10.1093/jncics/pkab063.
View
19.
DeSantis C, Fedewa S, Sauer A, Kramer J, Smith R, Jemal A
. Breast cancer statistics, 2015: Convergence of incidence rates between black and white women. CA Cancer J Clin. 2015; 66(1):31-42.
DOI: 10.3322/caac.21320.
View
20.
Ellis L, Canchola A, Spiegel D, Ladabaum U, Haile R, Gomez S
. Racial and Ethnic Disparities in Cancer Survival: The Contribution of Tumor, Sociodemographic, Institutional, and Neighborhood Characteristics. J Clin Oncol. 2017; 36(1):25-33.
PMC: 5756323.
DOI: 10.1200/JCO.2017.74.2049.
View